Association Between Type 2 Diabetes and All-Cause Hospitalization and Mortality in the UK General Heart Failure Population: Stratification by Diabetic Glycemic Control and Medication Intensification

JACC: Heart Failure

Volumn 6, Issue 1, 2018, Pages 18-26

  Lawson, Claire A ^a,b   Jones, Peter W ^b   Teece, Lucy ^b   Dunbar, Sandra B ^c   Seferovic, Petar M ^d   Khunti, Kamlesh ^a   Mamas, Mamas ^b   Kadam, Umesh T ^a,b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

comorbidity; death; diabetes mellitus; heart failure; hospitalization; prognosis

Indexed keywords

HEMOGLOBIN A1C; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

AGED; ALL CAUSE HOSPITALIZATION; ALL CAUSE MORTALITY; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GLYCEMIC CONTROL; HEART FAILURE; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT DURATION; UNITED KINGDOM; BLOOD; CLINICAL TRIAL; COMPLICATION; EPIDEMIOLOGY; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART STROKE VOLUME; METABOLISM; MORTALITY; MULTICENTER STUDY; ODDS RATIO; PATHOPHYSIOLOGY; PROGNOSIS; PROSPECTIVE STUDY; REGISTER; RISK FACTOR; SURVIVAL RATE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GLYCATED HEMOGLOBIN A; HEART FAILURE; HOSPITALIZATION; HUMANS; HYPOGLYCEMIC AGENTS; MALE; ODDS RATIO; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; STROKE VOLUME; SURVIVAL RATE; UNITED KINGDOM;

EID: 85030859780     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2017.08.020     Document Type: Article

References (30)

1. Rushton, C.A., Satchithananda, D.K., Jones, P.W., Kadam, U.T., Non-cardiovascular comorbidity, severity and prognosis in non-selected heart failure populations: A systematic review and meta-analysis. Int J Cardiol 196 (2015), 98–106.
2. Aguilar, D., Heart failure, diabetes mellitus, and chronic kidney disease: a clinical conundrum. Circ Heart Fail, 9, 2016, e003316.
3. Zinman, B., Wanner, C., Lachin, J.M., et al., EMPA-REG OUTCOME Investigators. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373 (2015), 2117–2128.
4. Funnell MM. 4 Steps to Manage Your Diabetes for Life. NIH Publication no. 06-5492. 2006. Bethesda, MD: National Institutes of Health, National Diabetes Education Program.
5. Rydén, L., Grant, P., Anker, S., et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 34 (2013), 3035–3087.
6. Aguilar, D., Bozkurt, B., Ramasubbu, K., Deswal, A., Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes. J Am Coll Cardiol 54 (2009), 422–428.
7. Patel, P., Liang, L., Khazanie, P., et al. Antihyperglycemic medication use among Medicare beneficiaries with heart failure, diabetes mellitus, and chronic kidney disease. Circ Heart Fail, 9, 2016, e002638.
8. Gustafsson, I., Brendorp, B., Seibæk, M., et al. Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure. J Am Coll Cardiol 43 (2004), 771–777.
9. MacDonald, M., Jhund, P., Petrie, M., et al. Discordant short- and long-term outcomes associated with diabetes in patients with heart failure: importance of age and sex: a population study of 5.1 million people in Scotland. Circ Heart Fail 1 (2008), 234–241.
10. 1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Arch Intern Med 168 (2008), 1699–1704.
11. Herrett, E., Thomas, S., Schoonen, W., Smeeth, L., Hall, A., Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 69 (2010), 4–14.
12. Maru, S., Koch, G., Stender, M., et al. Antidiabetic drugs and heart failure risk in patients with type 2 diabetes in the U.K. primary care setting. Diabetes Care 28 (2005), 20–26.
13. McDonald, H., Thomas, S., Millett, E., Nitsch, D., CKD and the risk of acute, community-acquired infections among older people with diabetes mellitus: a retrospective cohort study using electronic health records. Am J Kidney Dis 66 (2015), 60–68.
14. Essebag, V., Platt, R., Abrahamowicz, M., Pilote, L., Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure. BMC Med Res Methodol, 5, 2005, 5.
15. Department for Communities and Local Government. English Indices of Deprivation 2010: Guidance Document 2011. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/6871/1871208.pdf. Accessed June 8, 2015.
16. Seaman, S., Keogh, R., Handling missing data in matched case-control studies using multiple imputation. Biometrics 71 (2015), 1150–1159.
17. Rothman, K., Epidemiology, An Introduction. 2nd edition, 2012, Oxford University Press, New York, NY.
18. 1c) in people with type 2 diabetes: a retrospective cohort study. Lancet 375 (2010), 481–489.
19. Hippisley-Cox, J., Pringle, M., Prevalence, care, and outcomes for patients with diet-controlled diabetes in general practice: cross sectional survey. Lancet 364 (2004), 423–428.
20. MacDonald, M., Eurich, D., Majumdar, S., et al. Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case–control study from the U.K. General Practice Research Database. Diabetes Care 33 (2010), 1213–1218.
21. Goodlin, S., Palliative care in congestive heart failure. J Am Coll Cardiol 54 (2009), 386–396.
22. 1c levels and mortality in patients with diabetes and advanced systolic heart failure. Am Heart J, 151, 2006, 91.
23. 1c and mortality in diabetic individuals with heart failure: a population cohort study. Eur J Heart Fail 18 (2016), 94–102.
24. Eshaghian, S., Horwich, T., Fonarow, G., Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol 97 (2006), 1759–1764.
25. 1c and late mortality in patients with heart failure after cardiac surgery. Am J Cardiol 111 (2013), 1209–1213.
26. Güder, G., Gelbrich, G., Edelmann, F., et al. Reverse epidemiology in different stages of heart failure. Int J Cardiol 184 (2016), 216–224.
27. Khunti, K., Davies, M., Majeed, A., Thorsted, B.L., Wolden, M.L., Paul, S.K., Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study. Diabetes Care 38 (2015), 316–322.
28. 1c values and mortality risk in type 2 diabetes. Population-based case-control study. PLoS One, 8, 2013, e68008.
29. Güder, G., Gelbrich, G., Edelmann, F., et al. Reverse epidemiology in different stages of heart failure. Int J Cardiol 184 (2016), 216–224.
30. Khunti, K., Davies, M., Majeed, A., Thorsted, B.L., Wolden, M.L., Paul, S.K., Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study. Diabetes Care 38 (2015), 316–322.